Formulation science
Taking a known molecule and making it behave better in a real patient's body — improving dissolution, masking taste, stabilising a compound in a climate where the cold chain is imperfect and the summer is unforgiving.
Research & development
The work behind
The work behind
the molecule.
We do not claim to discover new drugs. We do the harder, quieter work that sits between a known molecule and a medicine someone can actually take — stability, bioavailability, tolerability, adherence and cost. That gap is where most unmet need actually lives.
Our approach
We do not
We do not
discover molecules.
It would be dishonest to claim otherwise. Novel drug discovery is a decade-long, billion-dollar undertaking, and pretending to do it is a marketing exercise that helps no patient.
What we do instead is the work that sits between a known molecule and a medicine that actually reaches someone. That gap is enormous, and it is where most of the world's unmet need actually lives. A drug that requires refrigeration a rural clinic cannot provide is not available. A therapy that requires four doses a day is not adhered to. A formulation that degrades in a Karachi summer is not medicine — it is packaging.
Our sixty-two scientists work on exactly these problems: stability, bioavailability, tolerability, adherence and cost. It is unglamorous science. It is also the science that determines whether the molecule someone discovered thirty years ago does any good in the places we serve.
0
Scientists across four disciplines
0
Products in active development
0
Bioequivalence studies completed
₨0B
Five-year R&D commitment
Focus areas
Four problems
Four problems
worth solving.
Each one sounds technical. Each one is the difference between a prescription written and a patient actually getting better.
Bioequivalence
Proving, to international protocol, that our version delivers the same active moiety at the same rate as the reference. This is where the word 'generic' either earns its meaning or exposes itself.
Drug delivery
Extended-release matrices, enteric coatings and fixed-dose combinations that reduce the number of times a day a patient has to remember — because the best therapy is the one actually taken.
Analytical development
Method development and validation that can detect an impurity at a level a regulator has not yet asked about. We would rather find it than be told about it.
Collaboration
Good science is
Good science is
rarely solitary.
We partner with universities, contract research organisations and clinical investigators across the region — for bioequivalence work, for analytical method development, and for the honest external scrutiny that internal teams cannot provide themselves.
Academic partnershipsCRO collaboration
Investigator studiesAnalytical method transfer
Are you a scientist who
wants the work to matter?
We are consistently hiring formulation scientists, analytical chemists and stability specialists. The problems are real and the patients are nearby.